Medivation Announces Participation at Upcoming Investor

Medivation Announces Participation at Upcoming Investor Conferences 
SAN FRANCISCO, CA -- (Marketwire) -- 11/07/12 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
conferences: 


 
--  Patrick Machado, chief business and financial officer, will present at
    the Jefferies 2012 Global Healthcare Conference on November 14 at
    3:00p.m. in London.
--  David Hung, M.D., president and chief executive officer, will present
    at the Credit Suisse 2012 Healthcare Conference on November 14 at
    11:30a.m. in Phoenix, AZ.
--  David Hung, M.D., president and chief executive officer, will present
    at the 24th Annual Piper Jaffray Healthcare Conference on November 27
    at noon in New York, NY.

  
About Medivation
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com. 
Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101 
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900 
 
 
Press spacebar to pause and continue. Press esc to stop.